Magazine article from our research archive:
|
|
Pioglitazone may lower cardiovascular risk in CKD patients.(Cardiovascular Medicine)(Clinical report)
- Article from:
-
Family Practice News
- Article date:
-
February 1, 2008
- Author:
-
|
Copyright informationCOPYRIGHT 2008 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Treatment with pioglitazone might help lower the risk of cardiovascular events in patients with chronic kidney disease, the results of a large study suggest.
"CKD, as defined by a glomerular filtration rate of less than 60 mL/min per 1.73 [m.sup.2], is an independent risk factor for major adverse cardiovascular events and death in this high-risk population," the researchers said. "Our data suggest patients with diabetes and high risk identified by CKD can be treated effectively with pioglitazone."
The study, by Dr. Christian A. Schneider of the University of Cologne (Germany), and his associates, was traded by Takeda Pharmaceutical Co., which makes Actos ...
Related newspaper, magazine, and journal articles:
|
Extended dosing of darbepoetin alfa in patients with chronic kidney...
Nephrology Nursing Journal;
July 1, 2005 ;
700+ words
......one of the biggest threats to patients with CKD--cardiovascular disease (CVD...factors have been identified in patients with CKD, including the presence of anemia...cardiovascular risk factor for patients with CKD (Sarnak et al., 2003). Renal...
|
|
|
Assessment of the impact of weekly versus monthly erythropoiesis...
Nephrology Nursing Journal;
March 1, 2007 ;
700+ words
......CKD, and approximately 47% of patients with CKD are anemic (McClellan, Tran...effectively correct anemia in patients with CKD and improve outcomes (Piccoli...an increased burden on both patients with CKD and their families. An erythropoietic...
|
|
Drug-eluting stents beat CABG in kidney patients.(Nephrology)(coronary...
Internal Medicine News;
January 15, 2008 ;
502 words
......Earlier studies had suggested that patients with CKD might do better with coronary...non-drug-eluting stents or with CABG. Patients with CKD had significantly worse outcomes...alive, compared with 85% of the patients with CKD. For bare-metal stents, the...
|
|
|
Preventing amputations in patients with diabetes and chronic kidney...
Nephrology Nursing Journal;
January 1, 2004 ;
700+ words
......improving the survival of patients with diabetes and CKD include improvement in...the number one cause of CKD (Berman, 2001). Patients with diabetes and chronic...extremity amputation for patients with diabetes and CKD is much greater than those...
|
|
|
K/DOQI gets to the heart of managing dyslipidemias in patients with...
Nephrology Nursing Journal;
May 1, 2005 ;
700+ words
......the cardiovascular burden in patients with CKD. As a result, the National Kidney...treatment of dyslipidemias in patients with CKD, irregardless of the underlying...assessment of dsylipidemia in patients with CKD. The first guideline recommends...
|
|
Timely Referral Alone May Not Be Enough for Patients With Chronic Kidney...
Mayo Clinic Proceedings;
February 1, 2007 ;
685 words
......increasing incidence and prevalence of CKD, patients encounter long waiting times...quality of prereferral care of patients with CKD, we conducted a retrospective...and bone mineral metabolism in patients with CKD. In addition, a shared nephrology...
|
|
|
Late Referral of Patients With Chronic Kidney Disease: No Time to Waste
Mayo Clinic Proceedings;
November 1, 2006 ;
700+ words
......a substantial percentage of patients with CKD will have progression to CKD...costs. However, up to 64% of patients with CKD are still referred late. This...hand, late referral (LR) of patients with CKD to nephrologists is increasingly...
|
|
|
Intensive Lipid Lowering With Atorvastatin in Patients With Coronary...
Mayo Clinic Proceedings;
August 1, 2008 ;
700+ words
......without chronic kidney disease (CKD). PATIENTS AND METHODS: Following 8 weeks...data were available for 1431. Patients with CKD were defined as having a baseline...with or without mild to moderate CKD. PATIENTS AND METHODS The design of the...
|
|
Aranesp(R) Dosed Once-Monthly Maintains Hemoglobin Levels in Chronic...
PR Newswire;
April 4, 2003 ;
700+ words
......dL) in chronic kidney disease (CKD) patients with anemia. The preliminary results...erythropoietic treatments for anemia in CKD, patients are dosed between three times and...consistent with those expected in CKD patients, including infection, hypertension...
|
|
|
Darbepoetin Alfa Administration to Achieve and Maintain Target Hemoglobin...
Mayo Clinic Proceedings;
September 1, 2006 ;
700+ words
......with Aranesp study, enrolled patients with CKD who were not receiving dialysis...maintained hemoglobin for 1 year in patients with CKD who were not undergoing dialysis...cardiovascular morbidity and mortality in patients with CKD.3-8 Indeed, anemia is a cardiovascular...
|
|
|
Use of Erythropoiesis-Stimulating Agents in Patients With Anemia of...
Mayo Clinic Proceedings;
November 1, 2007 ;
700+ words
......States. Anemia is common in patients with stage 3 CKD and, if not corrected, contributes...guidelines to treat anemia of CKD in patients with treatment-responsive anemia...2 large target Hb trials of CKD patients6,7 and of a metaanalysis8 that...
|
|
Vitamin D might reduce death risk in chronic kidney disease patients
The Hindustan Times;
May 8, 2008 ;
352 words
......vitamin D can cut death risk among patients with chronic kidney disease (CKD), by one-fourth. Many patients with advanced CKD take the drug calcitriol, an oral...vitamin D may improve survival in patients with CKD who do not yet require dialysis...
|
See all results.
Or, try our
Advanced Search.
|